14 April 2025
The AusHealth Phage Therapy Centre: taking the fight to antimicrobial resistance
Achievements
General
Hospitals
Research
Antimicrobial resistance is predicted to cause 10 million deaths by 2050. Could phage therapy be the solution?

4 April 2025
Thinning out the competition: Platypep team narrows the field to a blockbuster peptide
Achievements
General
Research
The Platypep venom project, funded by AusHealth since 2016, has taken another step toward creating an Australian-made version of Ozempic.
The research team has successfully identified a ‘hero peptide’ – derived from platypus venom – that reduces food intake, prevents weight gain and improves metabolic health in mice.
The research team has successfully identified a ‘hero peptide’ – derived from platypus venom – that reduces food intake, prevents weight gain and improves metabolic health in mice.

1 April 2025
Congratulations to our 2024 CureCell Award winners!
Achievements
General
Research
We celebrated seven exceptional PhD students working on cutting-edge research in cell and biological therapies at a formal presentation last week. They each won $10,000.
Thanks to Professor Glenn King, who gave a fascinating snapshot of his research – turning novel peptides found in spider venoms into life-saving drugs for heart disease, stroke, epilepsy and more.
Thanks to Professor Glenn King, who gave a fascinating snapshot of his research – turning novel peptides found in spider venoms into life-saving drugs for heart disease, stroke, epilepsy and more.

27 March 2025
AI-powered clinical coding software ‘live and in the lab’
Achievements
General
Hospitals
Research
“It’s amazing! It’s taking us just five minutes to code a case instead of 20 minutes…”

17 March 2025
Scientist, attorney and biotech entrepreneur Dr Justin Coombs made AusHealth CEO
Achievements
General
Research
Dr Justin Coombs' appointment comes in the wake of outstanding growth enjoyed by the Adelaide-based charity.

11 March 2025
The rebirth of radioligand therapy – a novel approach to treating cancer
Achievements
General
Research
AusHealth’s Dr Justin Coombs attended the South Australian Radioligand Therapy Roundtable, co-hosted by Novartis, the University of Adelaide and the University of South Australia.
Here he explains why radioligand therapy is having a renaissance in the treatment of cancer ...
Here he explains why radioligand therapy is having a renaissance in the treatment of cancer ...
